+91-98 455 710 46 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
27 Nov 2014

What is 505(b)(2) applications?

/
Posted By
/
Comments0
/
505(b)(2) NDA allows drug companies to obtain Food and Drug Administration (FDA) approval of essentially “new” drugs without having to conduct the full complement of safety and efficacy trials, which is often the most time-consuming and expensive part of the drug development process. 

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.